Clinical Implications of Genetic Defects in G Proteins: Oncogenic Mutations in Gαs as the Molecular Basis for the McCune-Albright Syndrome
Open Access
- 31 December 1999
- journal article
- review article
- Published by Elsevier in Archives of Medical Research
- Vol. 30 (6) , 522-531
- https://doi.org/10.1016/s0188-4409(99)00075-2
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Increased Interleukin-6 Production in Mouse Osteoblastic MC3T3-E1 Cells Expressing Activating Mutant of the Stimulatory G ProteinJournal of Bone and Mineral Research, 1998
- Central Precocious Puberty in a Girl with McCune-Albright Syndrome Responds to Treatment with GnRH AnalogueJournal of Pediatric Endocrinology and Metabolism, 1998
- Distribution of Gs-? activating mutations in human thyroid tumors measured by subcloningZeitschrift für Krebsforschung und Klinische Onkologie, 1996
- Activating mutations of Gs protein in monostotic fibrous lesions of boneJournal of Orthopaedic Research, 1996
- Crystallization and Preliminary Crystallographic Studies of Giα1 and Mutants of Giα1 in the GTP and GDP-bound StatesJournal of Molecular Biology, 1994
- Severe endocrine and nonendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein GsThe Journal of Pediatrics, 1993
- Mitogenic, melanogenic, and cAMP responses of cultured neonatal human melanocytes to commonly used mitogensJournal of Cellular Physiology, 1992
- Mutation in the Gene Encoding the Stimulatory G Protein of Adenylate Cyclase in Albright's Hereditary OsteodystrophyNew England Journal of Medicine, 1990
- Treatment of Precocious Puberty in the McCune–Albright Syndrome with the Aromatase Inhibitor TestolactoneNew England Journal of Medicine, 1986
- OSTEODYSTROPHIA FIBROSAAmerican Journal of Diseases of Children, 1937